Clin Psychopharmacol Neurosci.  2017 Aug;15(3):261-268. 10.9758/cpn.2017.15.3.261.

The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity

  • 1Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • 2Shim Joo Cheol Psychiatry Clinic, Busan, Korea.
  • 3Department of Psychiatry, Busan Metropolitan Mental Hospital, Busan, Korea.
  • 4Department of Psychiatry, Sharing and Happiness Hospital, Busan, Korea.
  • 5Department of Psychiatry, Samsung Changwon Hospital, Sungkyunkwan University College of Medicine, Changwon, Korea.


The study's aim was to develop and standardize a Korean version of the University of California San Diego Performance-based Skills Assessment (K-UPSA), which is used to evaluate the daily living function of patients with schizophrenia.
Study participants were 78 patients with schizophrenia and 27 demographically matched healthy controls. We evaluated the clinical states and cognitive functions to verify K-UPSA's reliability and validity. For clinical states, the Positive and Negative Syndrome Scale, Clinical Global Impression-Schizophrenia scale, and Social and Occupational Functioning Assessment Scale and Schizophrenia Quality of Life Scale-fourth revision were used. The Schizophrenia Cognition Rating Scale, Short-form of Korean-Wechsler Adult Intelligence Scale, and Wisconsin Card Sorting Test were used to assess cognitive function.
The K-UPSA had statistically significant reliability and validity. The K-UPSA has high internal consistency (Cronbach's alpha, 0.837) and test-retest reliability (intra-class correlation coefficient, 0.381-0.792; p<0.001). The K-UPSA had significant discriminant validity (p<0.001). Significant correlations between the K-UPSA's scores and most of the scales and tests listed above demonstrated K-UPSA's concurrent validity (p<0.001).
The K-UPSA is useful to evaluate the daily living function in Korean patients with schizophrenia.


Cognitive function; Reliability; Schizophrenia; Validity
Full Text Links
  • CPN
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: